(redirected from Parkinsonian disorders)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Parkinsonian disorders: Parkinsonism, Parkinson's syndrome, parkinsonian syndrome


or Par·kin·son·ism  (pär′kĭn-sə-nĭz′əm)
1. A syndrome characterized by tremor, muscular rigidity, slowness of movement, and postural and balance abnormalities, caused by Parkinson's disease or other diseases or induced by trauma, infection, or a drug. Also called Parkinson's syndrome.
2. Parkinson's disease.

par′kin·so′ni·an (-sō′nē-ən) adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


a chronic condition of the nervous system marked especially by muscle tremors.
See also: Disease and Illness
-Ologies & -Isms. Copyright 2008 The Gale Group, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Parkinsonism - a degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination
tremor - shaking or trembling (usually resulting from weakness or stress or disease)
degenerative disorder - condition leading to progressive loss of function
brain disease, brain disorder, encephalopathy - any disorder or disease of the brain
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.


n parkinsonismo
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Anle138b is a small molecule compound that specifically binds toxic oligomeric structures of alpha-synuclein, the core aggregating protein species in Parkinsonian disorders.
Walz et al., "Depressive symptoms are frequent in atypical parkinsonian disorders," Movement Disorders Clinical Practice, vol.
Thus, there is a need to identify a suitable presurgical neuropsychological protocol, which is sufficiently sensitive to both the typical cognitive dysfunction displayed in PD and atypical cognitive decline, as seen in other Parkinsonian disorders and has clear guidelines for its interpretation.
Abnormal echogenicity of the substantia nigra, raphe nuclei, and third-ventricle width as markers of cognitive impairment in Parkinsonian disorders: A cross-sectional study.
Therapeutic options for nocturnal problems in Parkinson's disease and atypical parkinsonian disorders. Journal of Neural Transmission.
In 90% of individuals with Parkinson's disease (PD) the area of echogenicity at the anatomical site of the SN is abnormally large (e.g., >0.20 [cm.sup.2]; SN+) [1] compared to just 10% of age-matched controls and patients with atypical Parkinsonian disorders [2].